STIM

STIM

USD

Neuronetics Inc. Common Stock

$2.870+0.490 (20.588%)

السعر في الوقت الحقيقي

Healthcare
الأجهزة الطبية
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$2.380

الأعلى

$3.090

الأدنى

$2.380

الحجم

0.12M

أساسيات الشركة

القيمة السوقية

189.8M

الصناعة

الأجهزة الطبية

البلد

United States

إحصاءات التداول

متوسط الحجم

1.33M

البورصة

NGM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $0.52الحالي $2.870الأعلى $5.92

أخبار ذات صلة

GlobeNewswire

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted

عرض المزيد
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
GlobeNewswire

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life

عرض المزيد
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

عرض المزيد
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

عرض المزيد
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.